Biotech and Life Sciences, M&A/Exit Deals, Quebec
Eli Lilly to pay $383M to buy out TVM Capital to own 100% of AurKa Pharma
Biotech and Life Sciences, M&A/Exit Deals, Quebec
British Columbia, Biotech and Life Sciences, M&A/Exit Deals, Ontario
Alberta, Biotech and Life Sciences, M&A/Exit Deals, Ontario
Biotech and Life Sciences, IPO, RTO Deals, United States
Alberta, Private Equity Deals, Biotech and Life Sciences
British Columbia, Biotech and Life Sciences, Government Funding
British Columbia, Biotech and Life Sciences, Government Funding
Private Equity Deals, Biotech and Life Sciences, Ontario, United States
Venture Capital Deals, Biotech and Life Sciences, Quebec
British Columbia, Biotech and Life Sciences, Private Deals, Ontario
British Columbia, Biotech and Life Sciences, Private Deals, United States
Biotech and Life Sciences, M&A/Exit Deals, Ontario
Biotech and Life Sciences, IPO, RTO Deals, United States